• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多种无偏方法鉴定角鲨烯环氧化酶为一种有前景的抗利什曼原虫药物的作用靶点。

Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial.

机构信息

Division of Biological Chemistry and Drug Discovery, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK.

Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK.

出版信息

Cell Chem Biol. 2021 May 20;28(5):711-721.e8. doi: 10.1016/j.chembiol.2021.02.008. Epub 2021 Mar 9.

DOI:10.1016/j.chembiol.2021.02.008
PMID:33691122
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8153249/
Abstract

Phenotypic screening identified a benzothiophene compound with activity against Leishmania donovani, the causative agent of visceral leishmaniasis. Using multiple orthogonal approaches, oxidosqualene cyclase (OSC), a key enzyme of sterol biosynthesis, was identified as the target of this racemic compound and its enantiomers. Whole genome sequencing and screening of a genome-wide overexpression library confirmed that OSC gene amplification is associated with resistance to compound 1. Introduction of an ectopic copy of the OSC gene into wild-type cells reduced susceptibility to these compounds confirming the role of this enzyme in resistance. Biochemical analyses demonstrated the accumulation of the substrate of OSC and depletion of its product in compound (S)-1-treated-promastigotes and cell-free membrane preparations, respectively. Thermal proteome profiling confirmed that compound (S)-1 binds directly to OSC. Finally, modeling and docking studies identified key interactions between compound (S)-1 and the LdOSC active site. Strategies to improve the potency for this promising anti-leishmanial are proposed.

摘要

表型筛选鉴定出一种苯并噻吩类化合物,该化合物对引起内脏利什曼病的利什曼原虫具有活性。利用多种正交方法,发现角鲨烯环化酶(OSC),一种固醇生物合成的关键酶,是该外消旋化合物及其对映异构体的作用靶点。全基因组测序和全基因组过表达文库筛选证实,OSC 基因扩增与对化合物 1 的耐药性有关。将 OSC 基因的异位拷贝导入野生型细胞中,降低了对这些化合物的敏感性,证实了该酶在耐药性中的作用。生化分析表明,在化合物(S)-1 处理的前鞭毛体和无细胞膜制剂中,OSC 的底物积累,产物耗尽。热蛋白质组谱分析证实化合物(S)-1 直接与 OSC 结合。最后,建模和对接研究确定了化合物(S)-1 与 LdOSC 活性位点之间的关键相互作用。提出了提高这种有前途的抗利什曼原虫药物效力的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/00cddb30fd13/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/64ef7f093ce8/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/931817adbb12/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/520cc538e5e8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/ace32ec911a2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/ca632b31df7d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/01db114a75d0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/a1a04425a6c4/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/00cddb30fd13/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/64ef7f093ce8/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/931817adbb12/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/520cc538e5e8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/ace32ec911a2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/ca632b31df7d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/01db114a75d0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/a1a04425a6c4/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/8153249/00cddb30fd13/fx2.jpg

相似文献

1
Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial.多种无偏方法鉴定角鲨烯环氧化酶为一种有前景的抗利什曼原虫药物的作用靶点。
Cell Chem Biol. 2021 May 20;28(5):711-721.e8. doi: 10.1016/j.chembiol.2021.02.008. Epub 2021 Mar 9.
2
Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.2,4-二氨基喹唑啉作为锥虫和利什曼原虫二氢叶酸还原酶抑制剂的设计、合成与评价
Bioorg Med Chem. 2005 Apr 1;13(7):2637-49. doi: 10.1016/j.bmc.2005.01.025.
3
Arylpiperidines as a new class of oxidosqualene cyclase inhibitors.芳基哌啶类作为新型角鲨烯环氧化酶抑制剂。
Eur J Med Chem. 2016 Feb 15;109:13-22. doi: 10.1016/j.ejmech.2015.12.025. Epub 2015 Dec 17.
4
Novel 4-piperidinopyridine inhibitors of oxidosqualene cyclase-lanosterol synthase derived by consideration of inhibitor pK(a).通过考虑抑制剂的pK(a)得到的新型氧化角鲨烯环化酶-羊毛甾醇合酶的4-哌啶基吡啶抑制剂。
Bioorg Med Chem Lett. 2001 Aug 20;11(16):2213-6. doi: 10.1016/s0960-894x(01)00423-1.
5
Design, Synthesis of Biaryl Piperidine Derivatives and Their Evaluation as Potential Antileishmanial Agents against Leishmania donovani Strain Ag83.设计、合成联苯哌啶衍生物及其作为潜在抗利什曼原虫药物对利什曼原虫 Ag83 株的评价。
Chem Biodivers. 2021 Jul;18(7):e2100105. doi: 10.1002/cbdv.202100105. Epub 2021 Jun 4.
6
Design strategies of oxidosqualene cyclase inhibitors: Targeting the sterol biosynthetic pathway.氧化角鲨烯环化酶抑制剂的设计策略:靶向甾醇生物合成途径。
J Steroid Biochem Mol Biol. 2017 Jul;171:305-317. doi: 10.1016/j.jsbmb.2017.05.002. Epub 2017 May 4.
7
In silico screening, structure-activity relationship, and biologic evaluation of selective pteridine reductase inhibitors targeting visceral leishmaniasis.针对内脏利什曼病的选择性喋呤还原酶抑制剂的计算机筛选、结构-活性关系和生物学评价。
Antimicrob Agents Chemother. 2011 Feb;55(2):659-66. doi: 10.1128/AAC.00436-10. Epub 2010 Nov 29.
8
A novel series of 4-piperidinopyridine and 4-piperidinopyrimidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase.一系列新型的2,3-氧化角鲨烯环化酶-羊毛甾醇合酶的4-哌啶基吡啶和4-哌啶基嘧啶抑制剂。
J Med Chem. 2000 Dec 28;43(26):4964-72. doi: 10.1021/jm000139k.
9
A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line.一种用于在THP1人急性单核细胞白血病细胞系中针对细胞内杜氏利什曼原虫无鞭毛体进行抗利什曼原虫筛选的寄生虫拯救与转化试验。
J Vis Exp. 2012 Dec 30(70):4054. doi: 10.3791/4054.
10
Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase.从人氧化角鲨烯环化酶的结构洞察甾体骨架的形成。
Nature. 2004 Nov 4;432(7013):118-22. doi: 10.1038/nature02993.

引用本文的文献

1
Antitrypanosomal quinazolines targeting lysyl-tRNA synthetase show partial efficacy in a mouse model of acute Chagas disease.靶向赖氨酰-tRNA合成酶的抗锥虫喹唑啉类药物在急性恰加斯病小鼠模型中显示出部分疗效。
Sci Transl Med. 2025 Jul 9;17(806):eadu4564. doi: 10.1126/scitranslmed.adu4564.
2
Investigating Antiprotozoal Chemotherapies with Novel Proteomic Tools-Chances and Limitations: A Critical Review.运用新型蛋白质组学工具研究抗寄生虫化学疗法:机遇与局限——批判性综述。
Int J Mol Sci. 2024 Jun 24;25(13):6903. doi: 10.3390/ijms25136903.
3
Sterol 14-alpha demethylase (CYP51) activity in Leishmania donovani is likely dependent upon cytochrome P450 reductase 1.

本文引用的文献

1
The Q Site of Cytochrome is a Promiscuous Drug Target in and .细胞色素的 Q 位点是 和 中的一个混杂药物靶点。
ACS Infect Dis. 2020 Mar 13;6(3):515-528. doi: 10.1021/acsinfecdis.9b00426. Epub 2020 Jan 30.
2
Nonparametric Analysis of Thermal Proteome Profiles Reveals Novel Drug-binding Proteins.非参数热蛋白质组谱分析揭示新型药物结合蛋白。
Mol Cell Proteomics. 2019 Dec;18(12):2506-2515. doi: 10.1074/mcp.TIR119.001481. Epub 2019 Oct 3.
3
The European Medicines Agency's scientific opinion on oral fexinidazole for human African trypanosomiasis.
利什曼原虫中的甾醇 14-α 脱甲基酶(CYP51)的活性可能依赖于细胞色素 P450 还原酶 1。
PLoS Pathog. 2024 Jul 11;20(7):e1012382. doi: 10.1371/journal.ppat.1012382. eCollection 2024 Jul.
4
CRISPR-Cas9 high-throughput screening to study drug resistance in .用于研究……中耐药性的CRISPR-Cas9高通量筛选
mBio. 2024 Jul 17;15(7):e0047724. doi: 10.1128/mbio.00477-24. Epub 2024 Jun 12.
5
Identification and Validation of Compounds Targeting Leucyl-Aminopeptidase M17.鉴定和验证靶向亮氨酰氨基肽酶 M17 的化合物
ACS Infect Dis. 2024 Jun 14;10(6):2002-2017. doi: 10.1021/acsinfecdis.4c00009. Epub 2024 May 16.
6
The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis.肽在对抗恰加斯病和利什曼病中的潜在应用。
Pharmaceutics. 2024 Feb 4;16(2):227. doi: 10.3390/pharmaceutics16020227.
7
The critical role of mode of action studies in kinetoplastid drug discovery.作用机制研究在动基体药物发现中的关键作用。
Front Drug Discov (Lausanne). 2023 May 10;3. doi: 10.3389/fddsv.2023.1185679.
8
Toolkit of Approaches To Support Target-Focused Drug Discovery for Lysyl tRNA Synthetase.赖氨酸 tRNA 合成酶靶向药物发现的方法工具包。
ACS Infect Dis. 2022 Sep 9;8(9):1962-1974. doi: 10.1021/acsinfecdis.2c00364. Epub 2022 Aug 29.
9
Identification of a Proteasome-Targeting Arylsulfonamide with Potential for the Treatment of Chagas' Disease.鉴定一种靶向蛋白酶体的芳基砜酰胺类化合物,有望用于治疗恰加斯病。
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0153521. doi: 10.1128/AAC.01535-21. Epub 2021 Oct 4.
10
Utilizing thermal proteome profiling to identify the molecular targets of anti-leishmanial compounds.利用热蛋白质组分析来鉴定抗利什曼原虫化合物的分子靶点。
STAR Protoc. 2021 Aug 18;2(3):100704. doi: 10.1016/j.xpro.2021.100704. eCollection 2021 Sep 17.
欧洲药品管理局关于口服非昔硝唑用于治疗人类非洲锥虫病的科学意见。
PLoS Negl Trop Dis. 2019 Jun 27;13(6):e0007381. doi: 10.1371/journal.pntd.0007381. eCollection 2019 Jun.
4
Target identification reveals lanosterol synthase as a vulnerability in glioma.靶标鉴定揭示羊毛甾醇合酶是神经胶质瘤的一个弱点。
Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7957-7962. doi: 10.1073/pnas.1820989116. Epub 2019 Mar 28.
5
The elimination of human African trypanosomiasis is in sight: Report from the third WHO stakeholders meeting on elimination of gambiense human African trypanosomiasis.消除人类非洲锥虫病在望:第三届世卫组织关于消除冈比亚型人类非洲锥虫病利益攸关方会议报告
PLoS Negl Trop Dis. 2018 Dec 6;12(12):e0006925. doi: 10.1371/journal.pntd.0006925. eCollection 2018 Dec.
6
The PRIDE database and related tools and resources in 2019: improving support for quantification data.PRIDE 数据库及相关工具和资源在 2019 年的进展:提高定量数据支持。
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450. doi: 10.1093/nar/gky1106.
7
Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani.N-肉豆蔻酰转移酶作为杜氏利什曼原虫药物靶点的药理学验证
ACS Infect Dis. 2019 Jan 11;5(1):111-122. doi: 10.1021/acsinfecdis.8b00226. Epub 2018 Nov 12.
8
Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition Metals.抗锥虫 8-羟基萘啶类药物是二价过渡金属的螯合剂。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00235-18. Print 2018 Aug.
9
What to expect and when: benznidazole toxicity in chronic Chagas' disease treatment.预期和时间:苯达唑治疗慢性恰加斯病的毒性。
J Antimicrob Chemother. 2018 Apr 1;73(4):1060-1067. doi: 10.1093/jac/dkx516.
10
Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cells.胆固醇生物合成抑制剂RO 48 - 8071可抑制激素依赖性和去势抵抗性前列腺癌细胞的生长。
Onco Targets Ther. 2016 May 30;9:3223-32. doi: 10.2147/OTT.S105725. eCollection 2016.